Page last updated: 2024-10-26

disopyramide and Anemia, Hemolytic

disopyramide has been researched along with Anemia, Hemolytic in 1 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Englert, M1

Other Studies

1 other study available for disopyramide and Anemia, Hemolytic

ArticleYear
[Supervision of patients with artificial heart valves (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1977, Dec-23, Volume: 119, Issue:51-52

    Topics: Anemia, Hemolytic; Disopyramide; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Monitoring

1977